DN-1289

1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

DN-1289 is an orally active and selective inhibitor of dual leucine zipper kinase (DLK; IC50=17 nM) and leucine zipper-bearing kinase (LZK; IC50=40 nM). DN-1289 results significant attenuation of optic nerve crush (ONC)-induced p-c-Jun in mice model. DN-1289 has excellent in vivo plasma half-life and blood-brain barrier permeability.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.63%
  • No. CAS: 3026597-15-6
  • Fòrmula: C18H19F4N7O2
  • Peso molecular:441.38
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) DN-1289

More

Ver todos los productos específicos de isoformas JNK

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00